Oxytocin in Individuals With Spectrum Autism Disorders
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Oxytocin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- Acronyms OxytocinASD
- 03 May 2019 Status changed from active, no longer recruiting to completed.
- 04 May 2018 Planned End Date changed from 29 Jul 2017 to 15 May 2018.
- 04 May 2018 Status changed from recruiting to active, no longer recruiting.